Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway

被引:105
作者
Feng, WJ
Webb, P
Nguyen, P
Liu, XH
Li, JD
Karin, M
Kushner, PJ [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit 1119 HSW, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1210/me.15.1.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect 88 activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these coactivators, which are known to mediate AF-1 action.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 88 条
  • [31] Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol
    IgnarTrowbridge, DM
    Pimentel, M
    Parker, MG
    McLachlan, JA
    Korach, KS
    [J]. ENDOCRINOLOGY, 1996, 137 (05) : 1735 - 1744
  • [32] JACOBS C, 1983, CANCER RES, V43, P1696
  • [33] Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase
    Joel, PB
    Traish, AM
    Lannigans, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) : 13317 - 13323
  • [34] Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
    Kalkhoven, E
    Valentine, JE
    Heery, DM
    Parker, MG
    [J]. EMBO JOURNAL, 1998, 17 (01) : 232 - 243
  • [35] c-jun Can recruit JNK to phosphorylate dimerization partners via specific docking interactions
    Kallunki, T
    Deng, TL
    Hibi, M
    Karin, M
    [J]. CELL, 1996, 87 (05) : 929 - 939
  • [36] A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
    Kamei, Y
    Xu, L
    Heinzel, T
    Torchia, J
    Kurokawa, R
    Gloss, B
    Lin, SC
    Heyman, RA
    Rose, DW
    Glass, CK
    Rosenfeld, MG
    [J]. CELL, 1996, 85 (03) : 403 - 414
  • [37] ACTIVATION OF THE ESTROGEN-RECEPTOR THROUGH PHOSPHORYLATION BY MITOGEN-ACTIVATED PROTEIN-KINASE
    KATO, S
    ENDOH, H
    MASUHIRO, Y
    KITAMOTO, T
    UCHIYAMA, S
    SASAKI, H
    MASUSHIGE, S
    GOTOH, Y
    NISHIDA, E
    KAWASHIMA, H
    METZGER, D
    CHAMBON, P
    [J]. SCIENCE, 1995, 270 (5241) : 1491 - 1494
  • [38] Transcription factor-specific requirements for coactivators and their acetyltransferase functions
    Korzus, E
    Torchia, J
    Rose, DW
    Xu, L
    Kurokawa, R
    McInerney, EM
    Mullen, TM
    Glass, CK
    Rosenfeld, MG
    [J]. SCIENCE, 1998, 279 (5351) : 703 - 707
  • [39] LE DB, 1996, EMBO J, V15, P6701
  • [40] LE GP, 1994, J BIOL CHEM, V269, P4458